IP Verse

Dry Power Inhaler Devices And Dry Power Formulations For Enhancing Dosing Efficiency - EP1617820

The patent EP1617820 was granted to Vectura on Mar 21, 2018. The application was originally filed on Apr 14, 2004 under application number EP04727320A. The patent is currently recorded with a legal status of "Revoked".

EP1617820

VECTURA
Application Number
EP04727320A
Filing Date
Apr 14, 2004
Status
Revoked
Feb 26, 2021
Grant Date
Mar 21, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

TEVA PHARMACEUTICALSDec 21, 2018ELKINGTON AND FIFEADMISSIBLE

Patent Citations (18) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTEP1213012
INTERNATIONAL-SEARCH-REPORTUS2002071871
INTERNATIONAL-SEARCH-REPORTUS2003055034
INTERNATIONAL-SEARCH-REPORTUS6045828
INTERNATIONAL-SEARCH-REPORTWO0113893
INTERNATIONAL-SEARCH-REPORTWO0178693
INTERNATIONAL-SEARCH-REPORTWO02067902
INTERNATIONAL-SEARCH-REPORTWO9116038
OPPOSITIONEP1213012
OPPOSITIONUS2002071871
OPPOSITIONUS2003055034
OPPOSITIONUS6045828
OPPOSITIONWO0113893
OPPOSITIONWO02067902
OPPOSITIONWO0243701
OPPOSITIONWO9116038
OPPOSITIONWO9623485
OPPOSITIONWO9703649

Non-Patent Literature (NPL) Citations (7) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- "Chapter 37", Gennaro, Remington: The Science and Practice of Pharmacy, (20000000), pages 681 - 685, XP055545952
OPPOSITION- "Delivery of Drugs by the Pulmonary Route", Banker G S., Et Al, Modern Pharmaceutics, (20020000), pages 479 - 499, XP055545934
OPPOSITION- R.J. MALCOMSON et al., "Dry powder formulations for pulmonary delivery", PSTT, (19981200), vol. 1, no. 9, pages 394 - 398, XP055545958
OPPOSITION- X.-M. ZENG et al., "Particle interactions in dry powder formulations for inhalation", Taylor & Francis, London and New York, (20010000), pages 133 - 138, XP055545914
OPPOSITION- P.R. BYRON et al., "OPTIMIZED INHALATION AEROSOLS I. THE EFFECTS OF SPHERICAL BAFFLE SIZE AND POSITION UPON THE OUTPUT OF SEVERAL PRESSURIZED NONAQUEOUS SUSPENSION FORMULATIONS", Pharm. Res., (19890000), vol. 6, pages 225 - 230, XP002944462
OPPOSITION- N.R. LABIRIS et al., Br. J. Clin. Pharmacol., (20030000), vol. 56, pages 600 - 612, XP055545966
OPPOSITION- A.J. HICKEY, "Lung Deposition and Clearance of Pharmaceutical Aerosols: What Can Be Learned from Inhalation Toxicology and Industrial Hygiene?", Aerosol Science and Technology, (19930000), vol. 18, pages 290 - 304, XP055539066

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents